Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and effectiveness of FK778 in liver transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• FK778

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Liver Transplantation | Phase 2 | Status: COMPLETED